Evidence map›Paper›PMID 42884060›Full record

ArticleInternational journal of molecular sciences2026

MoDeMol: A Decomposition-Based Evolutionary Framework for Multi-Objective Molecular Optimization.

Chenbin Guo, Cai Dai

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chenbin GuoSchool of Artificial Intelligence and Computer Science, Shaanxi Normal University, Xi'an 710119, China.
Cai DaiSchool of Artificial Intelligence and Computer Science, Shaanxi Normal University, Xi'an 710119, China.ORCID 0009-0002-4417-8532

Funding

National Natural Science Foundation of China 12271326National Natural Science Foundation of China 62102304Natural Science Basic Research Plan in Shaanxi Province of China 2022JM-354
6 · The paper itself

Abstract

Lead compound multi-objective optimization requires balancing mutually restrictive drug-like properties, yet conventional latent generative and evolutionary optimization methods suffer from structural-function misalignment, population structural redundancy and low search efficiency under limited evaluation budgets. This work proposes a decomposition-based evolutionary framework built on a score-informed latent space (MoDeMol), with four core innovations: (1) Contrastive fine-tuned Transformer-VAE latent space supervised by predicted dual-target activity scores to improve the alignment between latent spatial proximity and predicted target-activity profiles. (2) Hybrid population initialization combining lead latent perturbation and high-quality molecular bank screening to balance local scaffold retention and global high predicted-activity region exploration. (3) Adaptive resource allocation mechanism for dynamic subproblem computation scheduling to boost optimization efficiency when the property evaluation budget is limited. (4) Dynamic Morgan fingerprint similarity penalization to suppress structural redundancy and maintain diverse molecular scaffolds in the population. Extensive benchmarks on single-target GSK3β and dual-target GSK3β/JNK3 kinase optimization tasks demonstrate that MoDeMol outperforms MolFinder, JANUS and MOMO in success rate, Pareto hypervolume and qualified molecular yield. Quantitative latent-space analyses, qualitative visualization, scaffold tracking, and ablation experiments provide complementary evidence for the contributions of the proposed components. The proposed framework addresses representation alignment, structural redundancy, and search-resource allocation within a computational multi-target lead-optimization workflow under limited evaluation budgets.

Indexed as

AlgorithmsDrug DesignGlycogen Synthase Kinase 3 betaGlycogen Synthase Kinase 3 betalatent-space optimizationmolecular optimizationmulti-objective algorithm

Identifiers

PMID42884060
PMCPMC13665247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.